Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Urol. 2016 Jul 15;197(1):55–60. doi: 10.1016/j.juro.2016.07.040

Table 2.

Characteristics of patients treated in markets with no versus full integration

Number (%) No integration (n=19,848) Full integration (≥90%) (n=1,237) p-value
Age (years) 0.16
 66–69 5404 (27.2) 358 (28.9)
 70–74 6411 (32.3) 417 (33.7)
 75–79 4521 (22.8) 272 (22.0)
 80–84 2411 (12.1) 125 (10.1)
 85+ 1101 (5.5) 65 (5.3)
Race (%) <0.001
 White 15983 (80.5) 1134 (91.7)
 Black 1849 (9.3) 72 (5.8)
 Asian/Hispanic 1170 (5.9) 11 (0.9)
 Other 846 (4.3) 20 (1.6)
Charlson comorbidity index 0.01
 0 12093 (60.9) 809 (65.4)
 1 4628 (23.3) 265 (21.4)
 2 1753 (8.8) 87 (7.0)
 3 1374 (6.9) 76 (6.1)
D’Amico Risk 0.84
 Low 7514 (37.9) 462 (37.3)
 Intermediate 7312 (36.8) 466 (37.7)
 High 5022 (25.3) 309 (25.0)
Socioeconomic Status Tercile <0.001
 Low 7885 (39.7) 296 (23.9)
 Medium 5966 (30.1) 808 (65.3)
 High 5997 (30.2) 133 (10.8)
Urban <0.001
 ≥1 million metropolitan county 8659 (43.6) 916 (74.1)
 <1 million metropolitan county 7707 (38.8) 228 (18.4)
 Urban population of 2,500+ 3270 (16.5) 69 (5.6)
 Rural or <2,500 urban population 204 (1.0) 24 (1.9)
Urologists per 100,000 population <0.001
 Low (≤42.3) 9220 (46.5) >307*
 Intermediate 4220 (21.3) <11*
 High (≥71.5) 6408 (32.3) 919 (74.3)
Radiation oncologists per 100,000 population <0.001
 Low (≤19.2) 8285 (41.7) >137*
 Intermediate 4731 (23.8) 1097 (88.7)
 High (≥31.5) 6832 (34.4) <11*
Hospital beds per 100,000 population <0.001
 Low (≤4,028) 6115 (30.8) 85 (6.9)
 Intermediate 6858 (34.6) 28 (2.3)
 High (≥5,683) 6875 (34.6) 1124 (90.9)
Medicare Advantage penetration <0.001
 Low (≤15.8%) 11590 (58.4) >298*
 Intermediate 3720 (18.7) 929 (75.1)
 High (≥27.5%) 4538 (22.9) <11*
*

Exact value redacted/altered due to small cell size